CSIMarket
 
Casi Pharmaceuticals inc   (CASI)
Other Ticker:  
 
 


Deficit larger than a year ago at the Biotechnology & Pharmaceuticals company in the fiscal period closing September 30 2022

Casi Pharmaceuticals Inc recorded third quarter of 2022 operating shortfall of $-6.354 millions

Published 2022-11-16T03:23:29+00:00
Goran Soko / CSIMarket.com Contributer

closeup_By_Jean-Etienne_Minh-Duy_Poirrier_from_Bruxelles_Belgium_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons Casi Pharmaceuticals Inc announced in the Sep 30 2022 report surge in Revenues by 25.9 % to $10.21 millions from the comparable reporting season a year ago, but it has Losses have extended at $-0.38 per share.

In comparison to the previous period EPS improved from $-0.56 per share and Revenues improved by 19.13 % from $8.57 millions.

The business landscape for the company solutions continues to be robust among an ardently challenging sentiment at the suppliers, and CASI is focused on dealing with such environment invariably in order to catch up with promises and continuing with the next period business aims.
In the fiscal period closing September 30 2022 Casi Pharmaceuticals Inc reported net deficit of $-5.023 million, instead of deficit of $-10.019 millions in the comparable reporting season a year ago.


Casi Pharmaceuticals Inc is expected to report next financial recent numbers on March 27, 2023.


    Recently Reported Results
Tomography_(CAT)_scan_pd Haemonetics Corporation

The Medical Equipment & Supplies company declared memorable result, in the October to December 31 2022 span

HAE had impressive third quarter of 2022 financial report, where profit per share went up by 42.22 % to $0.64 per share, followed by Revenue rise of 17.528 % to $305.30 millions, compared with the prior year period.

factory_night_long_exposure_industry_power_industrial_energy_global-589754 Industrial production

The output of the nation's factories, mines and utilities fell in October by -0.1 %

Fed reported declining U.S. Industrial production in October, as the demand for industrial goods softens.

server-90389_960_720 Liveramp Holdings Inc

Excellent behavior by Liveramp Holdings Inc during the October to December 31 2022 interval

Although company's Revenues increased by 12.81 % from the same reporting season a year prior to $158.62 millions in the October to December 31 2022, Liveramp Holdings Inc increased a loss per share at $-0.46 loss per share.

Production by industry

Capacity utilization by industry

dna-163466__340 Incyte Corporation

It was very robust conduct by Incyte Corporation over the October to December 31 2022 span

Incyte Corporation announced earnings per share of $0.13 and Revenue of $823.30 millions in the fiscal span ending December 31 2022, company's income fell sharply $0.13 per share, versus $2.54 eps, earned in the fiscal span ending December 31 2021, although Incyte Corporation saw its Revenue rise by 7.4 % in the similar period.

Production by industry

Capacity utilization by industry

Mikroprozessor_By_Elmar_Ersch_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common Power Integrations Inc

The Top-line took a nose-dive at the company amid the financial fourth quarter of 2022

For the fourth quarter of 2022 company net profit per share dropped by -39.5 % of $0.40 per share compare to $0.66 a year ago and profit plummeted by -50.02 % from $0.80 per share from the prior reporting season.

Revenues crumbled by -27.734 % to $124.77 millions from $172.65 millions in the comparable reporting season a year ago and sequentially Revenues fell by -22.132 % from $160.23 millions.

Production by industry

Capacity utilization by industry

Warehouse_By Cayco_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common Retail Inventories

U.S. retail inventories rise in September

The retail inventories growth rate accelerated compare to the slow down in previous month, due to growing inventories at the car dealars.

workout_By_Nnu-12-22100541Tracy_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Productivity

Real Hourly Compensation continues to drop

Americans are earning less (inflation adjusted) per hour, despite the gain in productivity, as decline in manufacturing offset an increase in nonfarm business productivity.

Shopping_in_By_Ramunasjurevicius_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common Personal Income and Spending

U.S. incomes outpace spending in the November 2022

Americans turned thriftier in the November 2022, spending less and saving more, according to fresh government data.

Prosciutto_con_melone_By_Nikodem_Nijaki_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licensesby-sa3.0)]_via_Wikimedia_Commons The Hain Celestial Group Inc

Negligible dip in the Top-line at HAIN in the second quarter of 2022

For the fiscal second quarter of 2022 HAIN income per share dived by -63.64 % of $0.12 per share compare to $0.33 a year before and Income per Share soared by 50 % from $0.08 per share from the previous reporting period.

Revenues contracted by -4.766 % to $454.21 millions from $476.94 millions in the similar reporting period a year before and sequentially Revenues grew by 3.382 % from $439.35 millions.

Personal income and it's spending

Quarterly personal income

architecture-2256489_960_720.jpg Pathward Financial Inc

EPS Drops at the Pathward Financial Inc in the financial first quarter of 2022

In the most recent fiscal period the company announced soft top and bottom-line, where EPS plummeted by -51 % and revenue by -11.366 % year on year. Revenue were to $140.06 millions in contrast to $158.02 millions eps at $0.98 in proportion to $2.00 in the comparable period a prior year.

Personal income and it's spending

Quarterly personal income

NASDAQ_studio_By_Luis_Villa_del_Campo__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons Stonex Group Inc

Bewildering 1679.973%, gain in Revenues , by Stonex Group Inc over the most recent fiscal period

In spite of notable Revenue rise of 1679.973 % year on year to $13.01 billions in the financial three months ending December 31 2022, company's profitability turned positive at $3.62.

Personal income and it's spending

Quarterly personal income

Credit-cards_By_Lotus_Head_from_Johannesburg,_Gauteng,_South_Africa_(sxc.hu)__(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Riverview Bancorp Inc

Decrease in Income at RVSB amid the fiscal time-frame closing December 31 2022

Revenue rise of 1.295 %, could not prevent income decline of -4 % in the third quarter of 2022 financial report, compared to same reporting season a year ago. Revenues were at $16.66 millions and eps at $0.24.

Personal income and it's spending

Quarterly personal income

potato_field_crops_farm_soil_summer_plant_plow-521881 Brightview Holdings Inc

In spite of Strong Revenues Profitability not Reached by in the first quarter of 2022 earnings season

Although company's Revenues increased by 10.831 % from the similar financial reporting period a year ago to $655.90 millions in the first quarter of 2022 earnings season, Brightview Holdings Inc increased a loss per share at $-0.20 loss per share.

Personal income and it's spending

Quarterly personal income

closeup_By_Jean-Etienne_Minh-Duy_Poirrier_from_Bruxelles_Belgium_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons Exelixis Inc

Revenues receded by -6.034 %, at the company during the fourth quarter of 2022

For the fiscal fourth quarter of 2022 company slipped into deficit of $-0.09 per share compare to $0.29 a year before and EPS fell from $0.23 per share from the preceding financial reporting period.

Revenues decreased by -6.034 % to $423.92 millions from $451.14 millions in the similar financial reporting period a year before and sequentially Revenues advanced by 2.958 % from $411.74 millions.

Personal income and it's spending

Quarterly personal income



Other CASI's Earnings Reports

Casi Pharmaceuticals Inc reported third quarter 2022 earnings

Casi Pharmaceuticals Inc reported second quarter 2022 earnings

Casi Pharmaceuticals Inc reported first quarter 2022 earnings

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

KMX's Profile

Stock Price

KMX's Financials

Business Description

Fundamentals

Charts & Quotes

KMX's News

Suppliers

KMX's Competitors

Customers & Markets

Economic Indicators

KMX's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071